Robert, C. Lewis, K.D. Gutzmer, R. Stroyakovskiy, D. Gogas, H. Protsenko, S. Pereira, R.P. Eigentler, T. Rutkowski, P. Demidov, L. Caro, I. Forbes, H. Shah, K. Yan, Y. Li, H. McArthur, G.A. Ascierto, P.A., Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation–positive melanoma, Annals of Oncology, 2022, Elsevier Ireland Ltd, 0923-7534, 1569-8041